Market Trends of North America Blister Packaging Industry
This section covers the major market trends shaping the North America Blister Packaging Market according to our research experts:
Pharmaceutical is Expected to Witness a Significant Growth
- The pharmaceutical sector poses a different set of demands for blister packaging solutions, concerning insulation from external surroundings, cost-effectiveness, high levels of protection, and the ease of handling and retaining the effectiveness of the medicine. These packs are uniquely suited to meet stringent regulations and are highly valued for protective properties, cost-effectiveness, adaptability, and the pharmaceutical and packaging industry's requirements.
- When medicines are blister packaged, adherence is improved because consumers can keep track of their medications and dosage. The unit dosage feature of blisters reduces the risk of incorrect dosing.
- The retail-level preparation of prescription drugs is troubling pharmaceutical technicians or pharmacists. The administration of medicines in the open atmosphere of the supermarket and drug store may negatively affect sensitive medicines when they are transferred from container to container. Blister packaging can guarantee the process of distribution directly to the customer.
- Protecting product integrity continues to be the primary goal of pharmaceutical packaging, but there is continued work on cost reduction in the packaging process in all areas of the packaging industry.
- For instance, The Polybar barrier films product families provided by Amcor cover a wide range of moisture barriers whilst also providing good crush resistance to ensure the best protection for pharmaceutical applications such as tablets and capsules. It uses materials such as Aclar, COC, PE, PVC, and PVdc, among others.
- Further, the pharmaceutical companies catering to solid dose division are investing in the expansion of manufacturing facilities in North America. For instance, in September 2020, Aphena Pharma Solutions announced the expansion of the solid dose division in Cookeville, Tennessee. The comany has aimed to equip the facility with 24 high-speed bottling lines and eight thermoform blister packaging lines. This indicates the demand for blister packaging in the region.
- Moreover, according to The European Federation of Pharmaceutical Industries and Associations, North America accounted for 49% of the pharmaceutical revenue in 2020 compared to other regions across the globe. This increases demand for various blister packaging in the region.
United States to Hold the Largest Market Share
- Strict regulations, demands from manufacturers and consumers alike have led to growth in the usage of blister packages in the United States. The manufacturers are looking to earn tax incentives by manufacturing products under these regulatory standards. The promotion of Growth in over-the-counter drugs and has also provided an impetus to the market.
- Various chronic diseases raised the demand for drugs in the United States. Drug manufacturers introduced and invented effective drugs with advanced efficacies. This market also witnessed significant growth in the number of newer drug approvals given by the FDA.
- Under the blister packaging process, individual tablets or capsules are sealed within their own cavity, usually made of thermo-formed plastic or cold-form aluminum, protecting the drug from contaminants such as moisture and oxygen by a barrier of foil, film, or paperboard. Also, according to US Census Bureau, the manufacturing of pharmaceutical products could reach 365 thousand by the end of 2024. This further drives the market studied in the country.
- Furthermore, the outbreak has increased the research across the world for developing a vaccine for COVID-19. For instance, the healthcare giant, Johnson & Johnson, started clinical trials in September 2020 and has received a nearly USD 500 million partnership via a US Department of Health and Human Services division.